Find and Pitch Jounalists, Get Your Story Covered

Tags: CRISPR/Cas, gene silencing, genetics, knockout, RNA interference, TALENs, zinc finger nuclease biotechnology crispr drug development Drug prices

	Profile	Recent Articles on Subject
1	John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California biopharmadrugsdevices	Novartis gene therapy set to enhance SMA treatment - 25 days ago Bug in the system - about 1 year ago
2	Adam Feuerstein STAT News Reporter at STATnews. Dog lover. Polk Award winner. Boston, Massachusetts biotech reporting	STAT+: Biotech companies detail emerging efforts to ease ‘conditioning’ before genetic treatments - about 2 months ago STAT+: Perplexing results from Duchenne muscular dystrophy trial raise questions about gene therapies - 3 months ago In historic decision, FDA approves a CRISPR-based medicine for treatment of sickle cell disease - about 1 year ago
3	Jason Mast STAT News Writing about science, medicine. ScienceMedicineBusiness	STAT+: This father built a gene therapy for his son. Now comes the harder part: saving others’ children, too - about 2 months ago STAT+: Novartis buys gene therapy startup Kate Therapeutics, joining pursuit of muscular dystrophy treatment - 2 months ago STAT+: Perplexing results from Duchenne muscular dystrophy trial raise questions about gene therapies - 3 months ago STAT+: FDA rejects Rocket Pharmaceuticals’ gene therapy for ultra-rare condition, another setback for field - 7 months ago STAT+: Why the world’s most expensive drug might not be all that overpriced - 10 months ago STAT+: New gene therapy, to be priced at $4.25 million, has already transformed children’s lives - 11 months ago STAT+: FDA approves first gene therapy for fatal neuron disease in children - 11 months ago STAT+: Hemophilia gene therapies arrived after 40 years of struggle. Where are the patients? - 11 months ago STAT+: Doudna institute hatches plan to ‘cure hundreds of diseases’ left behind by CRISPR revolution - about 1 year ago STAT+: Could sickle cell someday be treated not with CRISPR, but with a pill? - about 1 year ago
4	Emily Mullin Wired Staff writer at WIRED. Covers biotechnology. Fall 2021 fellow. Pittsburgh, Pennsylvania biotechnology	The First Crispr Treatment Is Making Its Way to Patients - 3 months ago 6 Deaf Children Can Now Hear After a Single Injection - about 1 year ago Scientists Will Test a Cancer-Hunting mRNA Treatment - about 1 year ago In a World First, a Patient's Antibody Cells Were Just Genetically Engineered - about 1 year ago The First Crispr Medicine Is Now Approved in the US - about 1 year ago The First Crispr Medicine Just Got Approved - about 1 year ago A Single Infusion of a Gene-Editing Treatment Lowered High Cholesterol - about 1 year ago Crispr gene editing shown to permanently lower high cholesterol - about 1 year ago
5	Greg Laub MedPage Today Director of Video at MedPage Today. Screenwriter, previous managing editor. videographyscreenwritingediting	Novel Gene Therapy for Neovascular Age-Related Macular Degeneration - 3 months ago Bringing Gene Therapy to Age-Related Macular Degeneration - about 1 year ago
6	Meagan Parrish Pharma Voice Senior editor @industrydive. Pharma world follower. Wisconsin, USA pharmaceuticalsjournalismparenting	A sickle cell cure exists. But patients need more than just gene therapy. - 3 months ago
7	Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA medicalinnovation	On Heels of Positive Parkinson’s Gene Therapy Data, MeiraGTx Looks Ahead to Pivotal Test - 4 months ago
8	Randy Dotinga MedPage Today Indie scribbler, advocate. Board member, @ahcj. San Diego WritingAdvocacy	Gene Therapy Shows Promise in Rare Eye Disease That Causes Early Blindness - 5 months ago
9	Amy Baxter Pharma Voice Scientist, inventor, former pediatrician. Atlanta, Georgia pain relieftechnologyinnovation	Lilly lays down $1B to be ‘first in biology’ with obesity gene therapies - 5 months ago
10	Jonathan Wosen STAT News West Coast Biotech Reporter. Formerly @sdut. Stanford PhD. UCSC alum. San Diego, California BiotechLife SciencesImmunology	STAT+: Gene therapy pioneer Jim Wilson believes he can commercialize rare-disease drugs in a tough climate - 5 months ago STAT+: Bone marrow transplant advance could widen use of this less buzzy cure for sickle cell disease - about 1 year ago STAT+: Historic approval of sickle cell gene therapies met with cautious optimism by experts at ASH - about 1 year ago

Journalists covering Gene therapy